The cell-cycle checkpoint kinase Chk1 is required for mammalian homologous recombination repair

Sørensen, Claus Storgaard, Hansen, Lasse Tengbjerg, Dziegielewski, Jaroslaw, Syljuåsen, Randi G., Lundin, Cecilia, Bartek, Jiri, Helleday, Thomas·2005·Nature Cell Biology
DOI 10.1038/ncb1212

Cited by (662)

Items 101–200 of 662

  1. Replication Stress Induces Micronuclei Comprising of Aggregated DNA Double-Strand Breaks
    Bing Xu, Zhao-Liang Sun, Zhaojian Liu, Haiyang Guo, Qiao Liu, Haiyan Jiang, Yongxin Zou, Yaoqin Gong, Jay A. Tischfield, Changshun Shao · 2011 · PLoS ONE
  2. Clinical Candidates Targeting the ATR–CHK1–WEE1 Axis in Cancer
    Lukáš Górecki, Martin Andrš, Jan Korábečný · 2021 · Cancers
  3. The consequences of structural genomic alterations in humans: Genomic Disorders, genomic instability and cancer
    Rita Colnaghi, Gillian Carpenter, Marcel Volker, Mark O’Driscoll · 2011 · Seminars in Cell and Developmental Biology
  4. A potent Chk1 inhibitor is selectively cytotoxic in melanomas with high levels of replicative stress
    Kelly M. Brooks, Vanessa Oakes, Brooke Edwards, Max V. Ranall, Paul Leo, Sandra J. Pavey, Alex Pinder, Heather Beamish, Pamela Mukhopadhyay, Duncan Lambie et al. · 2012 · Oncogene
  5. PALB2 Regulates Recombinational Repair through Chromatin Association and Oligomerization
    Shirley M.-H. Sy, Michael S.Y. Huen, Yongyou Zhu, Junjie Chen · 2009 · Journal of Biological Chemistry
  6. XPO1 Inhibition using Selinexor Synergizes with Chemotherapy in Acute Myeloid Leukemia by Targeting DNA Repair and Restoring Topoisomerase IIα to the Nucleus
    Parvathi Ranganathan, Trinayan Kashyap, Xueyan Yu, Xiaomei Meng, Tzung-Huei Lai, Betina McNeil, Bhavana Bhatnagar, Sharon Shacham, Michael G. Kauffman, Adrienne M. Dorrance et al. · 2016 · Clinical Cancer Research
  7. Assessment of Chk1 Phosphorylation as a Pharmacodynamic Biomarker of Chk1 Inhibition
    Leslie A. Parsels, Yushen Qian, Daria M. Tanska, Marisa Gross, Lili Zhao, Maria C. Hassan, Sankari Arumugarajah, Joshua D. Parsels, Linda Hylander-Gans, Diane M. Simeone et al. · 2011 · Clinical Cancer Research
  8. DNA Damage Signalling and Repair Inhibitors: The Long-Sought-After Achilles’ Heel of Cancer
    Denis Velic, Anthony M. Couturier, Maria Ferreira, Amélie Rodrigue, Guy G. Poirier, Fabrice Fleury, Jean‐Yves Masson · 2015 · Biomolecules
  9. Targeting the Double-Strand DNA Break Repair Pathway as a Therapeutic Strategy
    Christopher J. Lord, Michelle Dawn Garrett, Alan Ashworth · 2006 · Clinical Cancer Research
  10. Phosphorylation of Rad55 on Serines 2, 8, and 14 Is Required for Efficient Homologous Recombination in the Recovery of Stalled Replication Forks
    Herzberg, Kristina, Bashkirov, Vladimir I., Rolfsmeier, Michael, Haghnazari, Edwin, McDonald, W. Hayes, Anderson, Scott, Bashkirova, Elena V., Yates, John R., Heyer, Wolf-Dietrich · 2006 · Molecular and Cellular Biology
  11. The role of RPA2 phosphorylation in homologous recombination in response to replication arrest
    Wei Shi, Zhihui Feng, Jiuqin Zhang, Ignacio González-Suárez, Robert P. Vanderwaal, Xiaohua Wu, Simon N. Powell, Joseph L. Roti Roti, Susana Gonzalo, Junran Zhang · 2010 · Carcinogenesis
  12. Transcription-Associated Recombination Is Dependent on Replication in Mammalian Cells
    Ponnari Gottipati, Tobias N. Cassel, Linda Savolainen, Thomas Helleday · 2007 · Molecular and Cellular Biology
  13. Rad17 recruits the MRE11‐RAD50‐NBS1 complex to regulate the cellular response to DNA double‐strand breaks
    Qinhong Wang, Michael Goldstein, Peter B. Alexander, Timothy P. Wakeman, Tao Sun, Junjie Feng, Zhenkun Lou, Michael B. Kastan, X.-F. Wang · 2014 · The EMBO Journal
  14. CCT244747 Is a Novel Potent and Selective CHK1 Inhibitor with Oral Efficacy Alone and in Combination with Genotoxic Anticancer Drugs
    Mike I. Walton, Paul D. Eve, Angela Hayes, Melanie R. Valenti, Alexis K. de Haven Brandon, Gary Box, Albert Hallsworth, Elizabeth L. Smith, Kathy J. Boxall, Michael D. Lainchbury et al. · 2012 · Clinical Cancer Research
  15. Achieving Precision Death with Cell-Cycle Inhibitors that Target DNA Replication and Repair
    Aimee K. Bence, Samuel McNeely, Richard Paul Beckmann · 2017 · Clinical Cancer Research
  16. Fission yeast Ccq1 is telomerase recruiter and local checkpoint controller
    Kazunori Tomita, Julia Promisel Cooper · 2008 · Genes & Development
  17. In vitro and in vivo genotoxicity of oxygenated polycyclic aromatic hydrocarbons
    Sarah McCarrick, Virginia F.P.M. Cunha, Ondřej Zapletal, Jan Vondráček, Kristian Dreij · 2018 · Environmental Pollution
  18. Defective Cell Cycle Checkpoints as Targets for Anti-Cancer Therapies
    Brian G. Gabrielli, Kelly M. Brooks, Sandra J. Pavey · 2012 · Frontiers in Pharmacology
  19. Sensitization of Pancreatic Cancer Stem Cells to Gemcitabine by Chk1 Inhibition
    Venkatasubbaiah A. Venkatesha, Leslie A. Parsels, Joshua D. Parsels, Lili Zhao, Sonya Zabludoff, Diane M. Simeone, Jonathan Maybaum, Theodore Steven Lawrence, Meredith Ann Morgan · 2012 · Neoplasia
  20. Human Embryonic Stem Cells Fail to Activate CHK1 and Commit to Apoptosis in Response to DNA Replication Stress
    Joëlle A. Desmarais, Michèle J. Hoffmann, Gregg Bingham, Mary E. Gagou, Mark Meuth, Peter W. Andrews · 2012 · Stem Cells
  21. Cleavage of Stalled Forks by Fission Yeast Mus81/Eme1 in Absence of DNA Replication Checkpoint
    Benoît Froget, Joël Blaisonneau, Sarah Lambert, Giuseppe Baldacci · 2007 · Molecular Biology of the Cell
  22. HDAC1 and HDAC2 integrate checkpoint kinase phosphorylation and cell fate through the phosphatase-2A subunit PR130
    Anja Göder, Claudia Emmerich, Teodora Nikolova, Nicole Kiweler, Maria Schreiber, Toni Kühl, Diana Imhof, Markus Christmann, Thorsten Heinzel, Günter Schneider et al. · 2018 · Nature Communications
  23. NER initiation factors, DDB2 and XPC, regulate UV radiation response by recruiting ATR and ATM kinases to DNA damage sites
    Ray, Alo, Milum, Keisha, Battu, Aruna, Wani, Gulzar, Wani, Altaf A. · 2013 · DNA Repair
  24. Targeting Poly(ADP-Ribose) Polymerase and the c-Myb–Regulated DNA Damage Response Pathway in Castration-Resistant Prostate Cancer
    Likun Li, Wenjun Chang, Guang Yang, Chengzhen Ren, Sanghee Park, Theodoros Karantanos, Styliani Karanika, Jianxiang Wang, Jianhua Yin, Parantu K. Shah et al. · 2014 · Science Signaling
  25. Regulation and pharmacological targeting of RAD51 in cancer
    McKenzie K. Grundy, Ronald J. Buckanovich, Kara Anne Bernstein · 2020 · NAR Cancer
  26. ATR/Chk1 pathway is essential for resumption of DNA synthesis and cell survival in UV-irradiated XP variant cells
    Despras, Emmanuelle, Daboussi, Fayza, Hyrien, Olivier, Marheineke, Kathrin, Kannouche, Patricia L. · 2010 · Human Molecular Genetics
  27. The AHR represses nucleotide excision repair and apoptosis and contributes to UV-induced skin carcinogenesis
    Marius Pollet, Siraz Shaik, Melina Mescher, Katrin Frauenstein, Julia Tigges, Stephan Alexander Braun, Kevin Sondenheimer, Mana Kaveh, Anika Bruhs, Stephan Meller et al. · 2018 · Cell Death and Differentiation
  28. Long noncoding RNA LINC02582 acts downstream of miR-200c to promote radioresistance through CHK1 in breast cancer cells
    Baiyao Wang, Jieling Zheng, Rong Li, Yunhong Tian, Jie Lin, Yingying Liang, Quanquan Sun, Anan Xu, Ronghui Zheng, Mengzhong Liu et al. · 2019 · Cell Death and Disease
  29. Discovery and in silico evaluation of aminoarylbenzosuberene molecules as novel checkpoint kinase 1 inhibitor determinants
    Rahul Singh, Vijay Kumar Bhardwaj, Jatin Sharma, Pralay Das, Rituraj Purohit · 2020 · Genomics
  30. Methylated DNA Causes a Physical Block to Replication Forks Independently of Damage Signalling, O6-Methylguanine or DNA Single-Strand Breaks and Results in DNA Damage
    Petra Groth, Simon Ausländer, Muntasir Mamun Majumder, Niklas Schultz, Fredrik Johansson, Eva Petermann, Thomas Helleday · 2010 · Journal of Molecular Biology
  31. Unique functions of CHK1 and WEE1 underlie synergistic anti-tumor activity upon pharmacologic inhibition
    Amy D. Guertin, Melissa M. Martin, Brian S. Roberts, Melissa S. Hurd, Xianlu Qu, Nathan R. Miselis, Yaping Liu, Jing Li, Igor Feldman, Yair Benita et al. · 2012 · Cancer Cell International
  32. Artesunate sensitizes ovarian cancer cells to cisplatin by downregulating RAD51
    Bingliang Wang, Dong Hou, Qiao Liu, Tingting Wu, Haiyang Guo, Xiyu Zhang, Yongxin Zou, Zhaojian Liu, Jinsong Liu, Jian‐Jun Wei et al. · 2015 · Cancer Biology & Therapy
  33. Prexasertib, a cell cycle checkpoint kinases 1 and 2 inhibitor, increases in vitro toxicity of PARP inhibition by preventing Rad51 foci formation in BRCA wild type high-grade serous ovarian cancer
    Ethan Brill, Takuhei Yokoyama, Jayakumar R. Nair, Minshu Yu, Yeong-Ran Ahn, Jung‐Min Lee · 2017 · Oncotarget
  34. Regulators of homologous recombination repair as novel targets for cancer treatment
    Małgorzata Krajewska, Rudolf S.N. Fehrmann, Elisabeth G.E. de Vries, Marcel A.T.M. van Vugt · 2015 · Frontiers in Genetics
  35. Uracil in DNA: Consequences for carcinogenesis and chemotherapy
    Sondra H. Berger, Douglas L. Pittman, Michael D. Wyatt · 2008 · Biochemical Pharmacology
  36. Chk1 inhibition and Wee1 inhibition combine synergistically to impede cellular proliferation
    Kurtis D. Davies, P. LouAnn Cable, Jennifer E. Garrus, Francis X. Sullivan, Ira von Carlowitz, Yvan Le Huérou, Eli M. Wallace, Richard D. Woessner, Stefan David Gross · 2011 · Cancer Biology & Therapy
  37. Sensitization of human cancer cells to gemcitabine by the Chk1 inhibitor MK-8776: cell cycle perturbation and impact of administration schedule in vitro and in vivo
    Ryan E. Montano, Ruth H. Thompson, Injae Chung, Huagang G. Hou, Nadeem Israr Khan, Alan R. Eastman · 2013 · BMC Cancer
  38. An ATR- and BRCA1-Mediated Fanconi Anemia Pathway Is Required for Activating the G2/M Checkpoint and DNA Damage Repair upon Rereplication
    Wenge Zhu, Anindya Dutta · 2006 · Molecular and Cellular Biology
  39. Inhibiting the DNA damage response as a therapeutic manoeuvre in cancer
    Nicola J. Curtin · 2013 · British Journal of Pharmacology
  40. Damage-induced DNA replication stalling relies on MAPK-activated protein kinase 2 activity
    Frederik Köpper, Cathrin Bierwirth, Margarete Schön, Meike Kunze, Ingegerd Elvers, Dominique Kranz, Priyanka Saini, M. Menon, David Walter, Claus Storgaard Sørensen et al. · 2013 · Proceedings of the National Academy of Sciences
  41. Curcumin suppresses multiple DNA damage response pathways and has potency as a sensitizer to PARP inhibitor
    Hideaki Ogiwara, Ayako Ui, Bunsyo Shiotani, Lee Zou, Akira Yasui, Takashi Kohno · 2013 · Carcinogenesis
  42. Dancing on Damaged Chromatin: Functions of ATM and the RAD50/MRE11/NBS1 Complex in Cellular Responses to DNA Damage
    Kenta Iijima, Maki Ohara, Ryota Seki, Hiroshi Tauchi · 2008 · Journal of Radiation Research
  43. Ceralasertib-Mediated ATR Inhibition Combined With Olaparib in Advanced Cancers Harboring DNA Damage Response and Repair Alterations (Olaparib Combinations)
    Haider Mahdi, Navid Hafez, Deborah B. Doroshow, Davendra P. S. Sohal, Vickie L. Keedy, Khanh T Do, Patricia Mucci LoRusso, Juliane Margarete Jürgensmeier, Manuel Avedissian, Jeffrey Sklar et al. · 2021 · JCO Precision Oncology
  44. Chk1 Inhibits E2F6 Repressor Function in Response to Replication Stress to Maintain Cell-Cycle Transcription
    Cosetta Bertoli, Steffi Klier, Clare H. McGowan, Curt Wittenberg, Robertus A.M. de Bruin · 2013 · Current Biology
  45. A genetic screen identifies BRCA2 and PALB2 as key regulators of G2 checkpoint maintenance
    Tobias Menzel, Viola Nähse, Arne Nedergaard Kousholt, Ditte Kjærsgaard Klein, Christin Lund‐Andersen, Michael James Lees, Jens Vilstrup Johansen, Randi G. Syljuåsen, Claus Storgaard Sørensen · 2011 · EMBO Reports
  46. Survival of the Replication Checkpoint Deficient Cells Requires MUS81-RAD52 Function
    Ivana Murfuni, Giorgia Basile, S.V. Subramanyam, Eva Malacaria, Margherita Bignami, Maria Spies, Annapaola Franchitto, Pietro Pichierri · 2013 · PLoS Genetics
  47. Modulation of the ATM/autophagy pathway by a G-quadruplex ligand tips the balance between senescence and apoptosis in cancer cells
    Beauvarlet, Jennifer, Bensadoun, Paul, Darbo, Elodie, Labrunie, Gaelle, Rousseau, Benoît, Richard, Elodie, Draskovic, Irena, Londono-Vallejo, Arturo, Dupuy, Jean-William, Nath Das, Rabindra et al. · 2019 · Nucleic Acids Research
  48. LRRC31 inhibits DNA repair and sensitizes breast cancer brain metastasis to radiation therapy
    Yanke Chen, Ting Jiang, Hongyi Zhang, Xingchun Gou, Cong Han, Jianhui Wang, Ann T. Chen, Jun Ma, Jun Liu, Zeming Chen et al. · 2020 · Nature Cell Biology
  49. Cyclin F suppresses B-Myb activity to promote cell cycle checkpoint control
    Ditte Kjærsgaard Klein, Saskia Hoffmann, Johanna K. Ahlskog, Karen A. O’Hanlon, Marianne Quaas, Brian Daniel Larsen, Baptiste Rolland, Heike I. Rösner, David Walter, Arne Nedergaard Kousholt et al. · 2015 · Nature Communications
  50. CtIP-dependent DNA resection is required for DNA damage checkpoint maintenance but not initiation
    Arne Nedergaard Kousholt, Kasper Fugger, Saskia Hoffmann, Brian Daniel Larsen, Tobias Menzel, Alessandro A. Sartori, Claus Storgaard Sørensen · 2012 · The Journal of Cell Biology
  51. RPA Mediates Recombination Repair During Replication Stress and Is Displaced from DNA by Checkpoint Signalling in Human Cells
    Kate M. Sleeth, Claus Storgaard Sørensen, Natalia Issaeva, Jaroslaw Dziegielewski, Jiří Bártek, Thomas Helleday · 2007 · Journal of Molecular Biology
  52. Homologous Recombination as a Replication Fork Escort: Fork-Protection and Recovery
    Audrey Costes, Sarah Lambert · 2012 · Biomolecules
  53. The fork and the kinase: A DNA replication tale from a CHK1 perspective
    Marina Alejandra González Besteiro, Vanesa Gottifredi · 2014 · Mutation Research/Reviews in Mutation Research
  54. USP1 deubiquitinase maintains phosphorylated CHK1 by limiting its DDB1-dependent degradation
    Jean-Hugues Guervilly, Emilie Renaud, Minoru Takata, Filippo Rosselli · 2011 · Human Molecular Genetics
  55. DNA Structure and Integrity Checkpoints during the Cell Cycle and Their Role in Drug Targeting and Sensitivity of Tumor Cells to Anticancer Treatment
    Andrzej Składanowski, Przemyslaw M. Bozko, Michał Sabisz · 2009 · Chemical Reviews
  56. The F-Box Domain-Dependent Activity of EMI1 Regulates PARPi Sensitivity in Triple-Negative Breast Cancers
    Antonio Marzio, Joseph Puccini, Youngho Kwon, Natalia Maverakis, Arnaldo Arbini, Patrick Sung, Dafna Bar‐Sagi, Michele Pagano · 2018 · Molecular Cell
  57. Wee1 Kinase: A Potential Target to Overcome Tumor Resistance to Therapy
    Francesca Esposito, Raffaella Giuffrida, Gabriele Raciti, Caterina Puglisi, Stefano Forte · 2021 · International Journal of Molecular Sciences
  58. The clinical development candidate CCT245737 is an orally active CHK1 inhibitor with preclinical activity in RAS mutant NSCLC and Eμ-MYC driven B-cell lymphoma
    Mike I. Walton, Paul D. Eve, Angela Hayes, Alan T. Henley, Melanie R. Valenti, Alexis K. de Haven Brandon, Gary Box, Kathy J. Boxall, Matthew Tall, Karen E. Swales et al. · 2015 · Oncotarget
  59. Inhibiting homologous recombination for cancer therapy
    Sophia B. Chernikova, John C. Game, J. Martin Brown · 2012 · Cancer Biology & Therapy
  60. Chk1 and Chk2 are differentially involved in homologous recombination repair and cell cycle arrest in response to DNA double-strand breaks induced by camptothecins
    Min Huang, Ze‐Hong Miao, Hong Zhu, Yu-Jun Cai, Wei Ping Lu, Jian Ding · 2008 · Molecular Cancer Therapeutics
  61. The protein phosphatase 1 regulator PNUTS is a new component of the DNA damage response
    Helga B. Landsverk, Felipe Mora‐Bermúdez, Ole J.B. Landsverk, Grete Hasvold, Soheil Naderi, Oddmund Bakke, Jan Ellenberg, Philippe Collas, Randi G. Syljuåsen, Thomas M. Küntziger · 2010 · EMBO Reports
  62. Prexasertib treatment induces homologous recombination deficiency and synergizes with olaparib in triple-negative breast cancer cells
    Chinnadurai Mani, Shirisha Jonnalagadda, Jojireddy Lingareddy, Sanjay Awasthi, William H. Gmeiner, Komaraiah Palle · 2019 · Breast Cancer Research
  63. Regulation of RAD51 at the Transcriptional and Functional Levels: What Prospects for Cancer Therapy?
    Esin Orhan, Carolina Velázquez, Imène Tabet, Claude Sardet, Charles G. Theillet · 2021 · Cancers
  64. RBM3-Regulated Genes Promote DNA Integrity and Affect Clinical Outcome in Epithelial Ovarian Cancer
    Õsa Ehlén, Björn Nodin, Elton Rexhepaj, Jenny Brändstedt, Mathias Uhlén, María Alvarado-Kristensson, Fredrik Pontén, Donal J. Brennan, Karin Jirström · 2011 · Translational Oncology
  65. Methyltransferase 1 is required for nonhomologous end‐joining repair and renders hepatocellular carcinoma resistant to radiotherapy
    Junbin Liao, Yi Yang, Xin Yue, Xiaoxue Wu, Meiyan Zhu, Yong Chen, Sui Peng, Ming Kuang, Shuibin Lin, Zhenwei Peng · 2022 · Hepatology
  66. Aurora‐A expressing tumour cells are deficient for homology‐directed DNA double strand‐break repair and sensitive to PARP inhibition
    Tony Sourisseau, Despina Maniotis, Afshan McCarthy, Chan Tang, Christopher J. Lord, Alan Ashworth, Spiros Linardopoulos · 2010 · EMBO Molecular Medicine
  67. Chk1 knockdown confers radiosensitization in prostate cancer stem cells
    XIAOBIN WANG, Zhikun Ma, ZHENG XIAO, Hui Liu, Zhongling Dou, Xiaoshan Feng, Haijun Shi · 2012 · Oncology Reports
  68. DNA damage repair in breast cancer and its therapeutic implications
    Reem Ali, Emad A. Rakha, Srinivasan Madhusudan, Helen E. Bryant · 2016 · Pathology
  69. Synergistic Effect of Olaparib with Combination of Cisplatin on PTEN -Deficient Lung Cancer Cells
    Daisuke Minami, Nagio Takigawa, Hiromasa Takeda, Minoru Takata, Nobuaki Ochi, Eiki Ichihara, Akiko Hisamoto, Katsuyuki Hotta, Mitsune Tanimoto, Katsuyuki Kiura · 2012 · Molecular Cancer Research
  70. A DNA-Damage Selective Role for BRCA1 E3 Ligase in Claspin Ubiquitylation, CHK1 Activation, and DNA Repair
    Ko Sato, Elayanambi Sundaramoorthy, Eeson Rajendra, Hiroyoshi Hattori, Anand Devaprasath D. Jeyasekharan, Nabieh Ayoub, Ralph Schiess, Ruedi H. Aebersold, Hiroyuki Nishikawa, Anna S. Sedukhina et al. · 2012 · Current Biology
  71. Breaking the DNA damage response to improve cervical cancer treatment
    Hylke W. Wieringa, Ate G.J. van der Zee, Elisabeth G.E. de Vries, Marcel A.T.M. van Vugt · 2015 · Cancer Treatment Reviews
  72. CHK1 overexpression in T-cell acute lymphoblastic leukemia is essential for proliferation and survival by preventing excessive replication stress
    Leonor Morais Sarmento, Vanda Póvoa, R. Nascimento, Gonçalo Real, Inês Antunes, Leila R. Martins, Catarina Ferreira Moita, Paula M. Alves, Miguel Abecasis, Luís F. Moita et al. · 2014 · Oncogene
  73. Tyrosine phosphorylation stimulates activity of human RAD51 recombinase through altered nucleoprotein filament dynamics
    S.V. Subramanyam, Mohammed Ismail, Ipshita Bhattacharya, Maria Spies · 2016 · Proceedings of the National Academy of Sciences
  74. Combined inhibition of Chk1 and Wee1 as a new therapeutic strategy for mantle cell lymphoma
    Rosaria Chilà, Alessandra Basana, Monica Lupi, Federica Guffanti, Eugenio Gaudio, Andrea Rinaldi, Luciano Cascione, Valentina Restelli, Chiara Tarantelli, Francesco Bertoni et al. · 2014 · Oncotarget
  75. ATM/ATR‐mediated phosphorylation of PALB2 promotes RAD51 function
    Johanna K. Ahlskog, Brian Daniel Larsen, Kavya Achanta, Claus Storgaard Sørensen · 2016 · EMBO Reports
  76. Synergism between Etoposide and 17-AAG in Leukemia Cells: Critical Roles for Hsp90, FLT3, Topoisomerase II, Chk1, and Rad51
    Qing Yao, Brenda J. Weigel, John Kersey · 2007 · Clinical Cancer Research
  77. Chk1 as a new therapeutic target in triple-negative breast cancer
    Laurence K. Albiges, Aïcha Goubar, Véronique Scott, Cécile Vicier, Céline Lefèbvre, Samar Alsafadi, Frédéric Commo, Mahasti Saghatchian, Vladimir Lazar, Philippe Dessen et al. · 2014 · The Breast
  78. Regulation of the Life Cycle of HPVs by Differentiation and the DNA Damage Response
    Shiyuan Hong, Laimonis A. Laimins · 2013 · Future Microbiology
  79. Translational research in radiation-induced DNA damage signaling and repair
    Jac A. Nickoloff, Mary‐Keara Boss, Chris Allen, Susan Μ. LaRue · 2017 · Translational Cancer Research
  80. Sub‐nuclear localization of Rad51 in response to DNA damage
    Emil Mladenov, Boyka Anachkova, Irina R. Tsaneva · 2006 · Genes to Cells
  81. PARP1 and CHK1 coordinate PLK1 enzymatic activity during the DNA damage response to promote homologous recombination-mediated repair
    Bin Peng, R. Shi, Jing Bian, Yuwei Li, Peipei Wang, Hailong Wang, Ji Liao, Wei‐Guo Zhu, Xingzhi Xu · 2021 · Nucleic Acids Research
  82. The Mre11 Nuclease Is Critical for the Sensitivity of Cells to Chk1 Inhibition
    Ruth H. Thompson, Ryan E. Montano, Alan R. Eastman · 2012 · PLoS ONE
  83. CBP and p300 Histone Acetyltransferases Contribute to Homologous Recombination by Transcriptionally Activating the BRCA1 and RAD51 Genes
    Hideaki Ogiwara, Takashi Kohno · 2012 · PLoS ONE
  84. Next-generation transcriptome sequencing of the premenopausal breast epithelium using specimens from a normal human breast tissue bank
    Ivanesa Pardo, Heather A. Lillemoe, Rachel J. Blosser, Mi-Ran Choi, Candice A. M. Sauder, Diane K Doxey, Theresa Mathieson, Bradley Allen Hancock, Dadrie F. Baptiste, Rutuja V. Atale et al. · 2014 · Breast Cancer Research
  85. Loss of CHK1 function impedes DNA damage-induced FANCD2 monoubiquitination but normalizes the abnormal G2 arrest in Fanconi anemia
    Jean-Hugues Guervilly, Gaëtane Macé‐Aimé, Filippo Rosselli · 2007 · Human Molecular Genetics
  86. Checkpoint kinase 1 inhibitors for potentiating systemic anticancer therapy
    Marcello Maugeri‐Saccà, Monica Bartucci, Ruggero D. Maria · 2012 · Cancer Treatment Reviews
  87. Recql5 Plays an Important Role in DNA Replication and Cell Survival after Camptothecin Treatment
    Yiduo Hu, Xincheng Lu, Guangjin Zhou, Ellen L. Barnes, Guangbin Luo · 2008 · Molecular Biology of the Cell
  88. ATR is a multifunctional regulator of male mouse meiosis
    Alexander Widger, Shantha K. Mahadevaiah, Julian Lange, Elias Elinati, Jasmin Zohren, Takayuki Hirota, Sarai Pacheco, Andros Maldonado-Linares, Marcello Stanzione, Obah A. Ojarikre et al. · 2018 · Nature Communications
  89. Inhibiting homologous recombination by targeting RAD51 protein
    Alexandre Demeyer, Houda Benhelli‐Mokrani, Benoı̂t Chénais, Pierre Weigel, Fabrice Fleury · 2021 · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer
  90. HMGA2 Inhibits Apoptosis through Interaction with ATR-CHK1 Signaling Complex in Human Cancer Cells
    Suchitra Natarajan, Sabine Hombach‐Klonisch, Peter Dröge, Thomas C. Klonisch · 2013 · Neoplasia
  91. Detection of Impaired Homologous Recombination Repair in NSCLC Cells and Tissues
    Moritz Alexander Birkelbach, Natalie Ferraiolo, Liliana Gheorghiu, Heike N. Pfäffle, Benedict D.T. Daly, Michael I. Ebright, Cheryl Spencer, Carl O’Hara, Johnathan R. Whetstine, Cyril H. Benes et al. · 2013 · Journal of Thoracic Oncology
  92. Checkpoint Kinase 1 Inhibition Enhances Cisplatin Cytotoxicity and Overcomes Cisplatin Resistance in SCLC by Promoting Mitotic Cell Death
    Wei‐Hsun Hsu, Xiaoliang Zhao, Jianquan Zhu, In‐Kyu Kim, Guanhua Rao, Justine N. McCutcheon, Shuo-Tse Hsu, Beverly A. Teicher, Bhaskar Kallakury, Afshin Dowlati et al. · 2019 · Journal of Thoracic Oncology
  93. ATR-Chk1 Axis Protects BCR/ABL Leukemia Cells from the Lethal Effect of DNA Double-Strand Breaks
    Margaret Nieborowska-Skorska, Tomasz Stokłosa, Mandrita Datta, Agnieszka Czechowska, Lori A. Rink, Artur Słupianek, Mateusz Koptyra, Ilona Seferyńska, Konrad Krszyna, Janusz Błasiak et al. · 2006 · Cell Cycle
  94. The Werner syndrome protein: linking the replication checkpoint response to genome stability
    Pietro Pichierri, Francesca Ammazzalorso, Margherita Bignami, Annapaola Franchitto · 2011 · Aging
  95. Emerging links between the biological clock and the DNA damage response
    Spencer James Collis, Simon J. Boulton · 2007 · Chromosoma
  96. Resistance to the CHK1 inhibitor prexasertib involves functionally distinct CHK1 activities in BRCA wild-type ovarian cancer
    Jayakumar R. Nair, Tzu‐Ting Huang, Junko Murai, Brittany M. Haynes, Patricia Schriver Steeg, Yves G. Pommier, Jung-Min Lee · 2020 · Oncogene
  97. Human single-stranded DNA binding protein 1 (hSSB1/NABP2) is required for the stability and repair of stalled replication forks
    Emma Bolderson, Eva Petermann, Laura V. Croft, Amila Suraweera, RAJ KUMAR PANDITA, Tej K. Pandita, Thomas Helleday, Kum Kum Khanna, Derek J. Richard · 2014 · Nucleic Acids Research
  98. Replication Checkpoint: Tuning and Coordination of Replication Forks in S Phase
    Nicole Hustedt, Susan M. Gasser, Kenji Shimada · 2013 · Genes
  99. The inhibition of PARP but not EGFR results in the radiosensitization of HPV/p16-positive HNSCC cell lines
    Julian David Güster, Stephanie Weißleder, Chia‐Jung Busch, Malte Kriegs, Cordula Petersen, Rainald Knecht, Ekkehard Dikomey, Thorsten Rieckmann · 2014 · Radiotherapy and Oncology
  100. Cooperative functions of Chk1 and Chk2 reduce tumour susceptibility in vivo
    Hiroyuki Niida, Kazuhiro Murata, Midori Shimada, Kumiko Ogawa, Kumiko Ohta, Kyoko Suzuki, Hidetsugu Fujigaki, Aik Kia Khaw, Birendranath Banerjee, Manoor Prakash Hande et al. · 2010 · The EMBO Journal